188 related articles for article (PubMed ID: 12881524)
1. Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A.
Pandini G; Medico E; Conte E; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2003 Oct; 278(43):42178-89. PubMed ID: 12881524
[TBL] [Abstract][Full Text] [Related]
2. IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding.
Pandini G; Conte E; Medico E; Sciacca L; Vigneri R; Belfiore A
Ann N Y Acad Sci; 2004 Dec; 1028():450-6. PubMed ID: 15650270
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
[TBL] [Abstract][Full Text] [Related]
4. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.
Scalia P; Heart E; Comai L; Vigneri R; Sung CK
J Cell Biochem; 2001; 82(4):610-8. PubMed ID: 11500939
[TBL] [Abstract][Full Text] [Related]
6. Insulin and insulin-like growth factor II differentially regulate endocytic sorting and stability of insulin receptor isoform A.
Morcavallo A; Genua M; Palummo A; Kletvikova E; Jiracek J; Brzozowski AM; Iozzo RV; Belfiore A; Morrione A
J Biol Chem; 2012 Mar; 287(14):11422-36. PubMed ID: 22318726
[TBL] [Abstract][Full Text] [Related]
7. Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
Brierley GV; Macaulay SL; Forbes BE; Wallace JC; Cosgrove LJ; Macaulay VM
Endocrinology; 2010 Apr; 151(4):1418-27. PubMed ID: 20179263
[TBL] [Abstract][Full Text] [Related]
8. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
9. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
[TBL] [Abstract][Full Text] [Related]
10. Selective response to insulin versus insulin-like growth factor-I and -II and up-regulation of insulin receptor splice variant B in the differentiated mouse mammary epithelium.
Berlato C; Doppler W
Endocrinology; 2009 Jun; 150(6):2924-33. PubMed ID: 19246539
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor type 1 receptor and insulin receptor isoform expression and signaling in mammary epithelial cells.
Rowzee AM; Ludwig DL; Wood TL
Endocrinology; 2009 Aug; 150(8):3611-9. PubMed ID: 19406949
[TBL] [Abstract][Full Text] [Related]
12. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor (IR) pathway hyperactivity in IGF-IR null cells and suppression of downstream growth signaling using the dual IGF-IR/IR inhibitor, BMS-754807.
Dinchuk JE; Cao C; Huang F; Reeves KA; Wang J; Myers F; Cantor GH; Zhou X; Attar RM; Gottardis M; Carboni JM
Endocrinology; 2010 Sep; 151(9):4123-32. PubMed ID: 20610571
[TBL] [Abstract][Full Text] [Related]
15. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A.
Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395
[TBL] [Abstract][Full Text] [Related]
16. Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain.
Denley A; Brierley GV; Carroll JM; Lindenberg A; Booker GW; Cosgrove LJ; Wallace JC; Forbes BE; Roberts CT
Endocrinology; 2006 Feb; 147(2):1029-36. PubMed ID: 16239300
[TBL] [Abstract][Full Text] [Related]
17. Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression.
Dupont J; Dunn SE; Barrett JC; LeRoith D
Recent Prog Horm Res; 2003; 58():325-42. PubMed ID: 12795426
[TBL] [Abstract][Full Text] [Related]
18. Circulating insulin-like growth factors may contribute substantially to insulin receptor isoform A and insulin receptor isoform B signalling.
Varewijck AJ; Brugts MP; Frystyk J; Goudzwaard JA; Uitterlinden P; Waaijers AM; Feng Y; Dimitrov DS; Lamberts SW; Hofland LJ; Janssen JA
Mol Cell Endocrinol; 2013 Jan; 365(1):17-24. PubMed ID: 22982059
[TBL] [Abstract][Full Text] [Related]
19. Delineation of the IGF-II C domain elements involved in binding and activation of the IR-A, IR-B and IGF-IR.
Henderson ST; Brierley GV; Surinya KH; Priebe IK; Catcheside DE; Wallace JC; Forbes BE; Cosgrove LJ
Growth Horm IGF Res; 2015 Feb; 25(1):20-7. PubMed ID: 25458127
[TBL] [Abstract][Full Text] [Related]
20. Decorin differentially modulates the activity of insulin receptor isoform A ligands.
Morcavallo A; Buraschi S; Xu SQ; Belfiore A; Schaefer L; Iozzo RV; Morrione A
Matrix Biol; 2014 Apr; 35():82-90. PubMed ID: 24389353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
